High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
about
Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the ArtRisk of Adverse Vascular Events in Newly Diagnosed Glioblastoma Multiforme Patients Treated with Bevacizumab: a Systematic Review and Meta-AnalysisIDH1 and IDH2 mutations as novel therapeutic targets: current perspectivesCurrent Therapeutic Advances Targeting EGFR and EGFRvIII in GlioblastomaPrevalence of Neurotropic Viruses in Malignant Glioma and Their Onco-Modulatory Potential.SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death.HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastomaPrognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study.Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.Girdin regulates the migration and invasion of glioma cells via the PI3K-Akt signaling pathway.Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling StudyInhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.Current Clinical Brain Tumor ImagingImpact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.18F-fluorothymidine PET imaging in gliomas: an update.ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors.Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas.Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital.Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score-matching analysis.Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme.On glioblastoma and the search for a cure: where do we stand?Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives.Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain TumorsTumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.The role of radiation in treating glioblastoma: here to stay.Benign ependymoma with extensive intracranial and spinal cerebrospinal fluid dissemination: case report and literature review.Current trends in the management of glioblastoma in a French University Hospital and associated direct costs.Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas.
P2860
Q26738787-AEAE06D5-5EBE-4D9A-9C91-07928FA77F62Q26783779-461A4C8F-BA74-411F-B3BF-9D77CFE6819EQ28066926-AEE729B3-50F5-450A-BECD-9C63025CB5EAQ28087306-F606EA43-7019-4329-A833-824AD0BE255CQ33622517-2D62143E-500C-4730-8B2B-17E2CFAD5E09Q33781657-047DBD43-357B-4D9E-914A-EBF1727B57C1Q34459264-A83152A3-E539-489E-B78E-ECB0ADF048B0Q34484456-AA00BB6A-4B50-41EC-A826-43FFF618E425Q35024449-73638488-4629-4AF4-894F-27F3DC16C586Q35203538-67B62594-8160-4E79-88A8-01BBEC92F999Q35765180-DB9B0881-846E-4D92-A558-D03992206418Q35835743-5F8248B8-2A94-4363-992F-11A392B18C7FQ35925839-6B7DEC8B-ECBE-43C2-BB15-EAA46A6F8345Q35943863-C0143656-3653-44DB-8465-C71F0F47A3D8Q36089868-55ED8678-CD24-4D12-A247-35D73860F282Q36151109-6EF3A227-69A7-4C79-8F6F-3A1AF98F3D58Q36247876-8AF27CE2-AF4E-4D09-A511-5F6AD7F4B7B6Q36367172-0F27A728-D662-4934-B123-60C505CA9CC6Q36399129-B4770502-0412-4484-BEEB-A075B8932DE7Q36404866-8B71D7A2-52F9-4035-A392-F947587F0B87Q37298192-7FAF2596-F453-4F28-9884-5B5E80A7BCE6Q37496863-54C4C6CC-6452-425D-89A9-4FECE0A0693FQ37525571-EFAEF9FE-D36D-4FA8-8F2B-78E18B908E95Q37675804-A1866F9F-2CF7-4290-A8A3-F9356A3591E0Q37712185-21F49FAA-CDDF-4713-90CD-E1FCE2F677CEQ38244033-E6C2B795-5561-4666-AB2B-46367B60ACE7Q38313730-757BADF2-03BF-4B6D-BE54-DCC66DA7C339Q38598949-18FE3B03-ACBB-453F-82D9-F429D6E6F7BEQ38690536-1363F13C-2CF7-470A-915A-B4FDA72D4E10Q38735518-3339CF8C-C69F-4FC1-874A-FAF8E431E48EQ38756293-E0CCEE0B-2541-468B-A722-D061C71E7E3FQ38845930-1CB9B3F9-EB1C-482F-8E4B-EA87E9666FB6Q38855171-E37473D1-51CE-41F4-A5D2-4014999F1E8FQ38997694-06E4E0A6-4519-4261-B204-8B3F9321077BQ38998571-D81C3769-43E6-4D49-9CF3-1A9E9BEC0841Q39167423-4BD43B23-97DB-457F-B345-F9B97F00D512Q39386457-6CC1202F-7306-412A-B251-D6CE334F617AQ40125960-755BBB0A-0F6D-497E-B47A-A3E8C611DA79Q40905063-DD6917D3-4CA4-4D70-A758-53C1141EFFC7Q41845885-A98084AA-169D-42E7-A2A0-8A528AC501F2
P2860
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
High-grade glioma: ESMO Clinic ...... osis, treatment and follow-up.
@en
High-grade glioma: ESMO Clinic ...... osis, treatment and follow-up.
@nl
type
label
High-grade glioma: ESMO Clinic ...... osis, treatment and follow-up.
@en
High-grade glioma: ESMO Clinic ...... osis, treatment and follow-up.
@nl
prefLabel
High-grade glioma: ESMO Clinic ...... osis, treatment and follow-up.
@en
High-grade glioma: ESMO Clinic ...... osis, treatment and follow-up.
@nl
P2093
P2860
P356
P1433
P1476
High-grade glioma: ESMO Clinic ...... nosis, treatment and follow-up
@en
P2093
ESMO Guidelines Working Group
G Pentheroudakis
P2860
P304
P356
10.1093/ANNONC/MDU050
P478
25 Suppl 3
P577
2014-04-29T00:00:00Z